^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ISET®-AML test

Company:
Rarecells
Type:
Laboratory Developed Test
Evidence

News

over2years
Rarecells, Inc. to fund a clinical study at Columbia University of its ISET® -AML test for early detection of acute myeloid leukemia (AML) (Rarecells Press Release)
"Rarecells, Inc.,.announced today that it has entered into an agreement with Columbia University to fund a clinical study evaluating its ISET® -AML test for early detection of acute myeloid leukemia (AML) in patients with myelodysplastic syndrome (MDS)...The study, expected to begin in Q1 2022, will be the first clinical evaluation of the ISET® -AML test."
Financing • Licensing / partnership • New trial
|
ISET®-AML test